← Leaderboards
Leonard L Howell
Emory University
$20,665,111
Attributed
$22,024,378
Total exposure
41
Grants
30
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–17$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$22,024,378 · 41
By mechanism
R01$13,037,464 · 4
R37$4,930,107 · 1
P51$2,029,712 · 32
K02$1,085,789 · 1
K05$618,680 · 1
R21$214,200 · 1
Top collaborators
- Mar M Sanchez4 shared
Most similar at Emory University
Same institution · by research overlap
- Reynaldo Martorell$4,943,445
- Michael A Nader$33,226,167
- Rebecca A Seligman$107,006
- Gina Maria Wingood$34,313,613
- Allan I Levey$89,469,218
Others in their field
Top investigators on “Cocaine”
- Sten H Vermund · University Of Alabama At Birmingham$115,253,143
- Fred M Gordin · Social And Scientific Systems, Inc.$44,160,542
- Eric J Nestler · Icahn School Of Medicine At Mount Sinai$42,690,128
- Joel Gelernter · Washington University$34,364,949
- Michael A Nader · Emory University$33,226,167
- Shenghan Lai · University Of Miami Coral Gables$31,568,530
Research focus
CocainePharmaceutical PreparationsDopamineNonhuman PrimateSelf AdministrationPositron-Emission TomographyBrainNeurochemistryMicrodialysisNeuropharmacologyMonoamineBehaviorMonkeysIn VivoSerotoninAttenuatedFundingBehavioralMacaca MulattaEffectivenessInhibitor/AntagonistCuesBehavioral PharmacologyNeuroimaging
Grant awards (99)
Early life stress and adolescent cocaine abuse: neurobiological vulnerabilities$630,096
R01 · FY2017 · DA
Early life stress and adolescent cocaine abuse: neurobiological vulnerabilities$728,953
R01 · FY2016 · DA
Neuropharmacology of Abused Stimulants in Nonhuman Primates$123,736
K05 · FY2016 · DA · contact PI
Early life stress and adolescent cocaine abuse: neurobiological vulnerabilities$605,076
R01 · FY2015 · DA
PET Imaging and Cocaine Neuropharmacology in Monkeys$604,023
R37 · FY2015 · DA · contact PI
Neuropharmacology of Abused Stimulants in Nonhuman Primates$123,736
K05 · FY2015 · DA · contact PI
Early life stress and adolescent cocaine abuse: neurobiological vulnerabilities$754,410
R01 · FY2014 · DA
PET Imaging and Cocaine Neuropharmacology in Monkeys$610,113
R37 · FY2014 · DA · contact PI
Cocaine Use and Monoamine Function$412,345
R01 · FY2014 · DA · contact PI
Neuropharmacology of Abused Stimulants in Nonhuman Primates$123,736
K05 · FY2014 · DA · contact PI
PET Imaging and Cocaine Neuropharmacology in Monkeys$584,484
R37 · FY2013 · DA · contact PI
Cocaine Use and Monoamine Function$437,515
R01 · FY2013 · DA · contact PI
Vulnerability biomarkers for cocaine abuse and relapse$214,200
R21 · FY2013 · DA · contact PI
Neuropharmacology of Abused Stimulants in Nonhuman Primates$123,736
K05 · FY2013 · DA · contact PI
PET Imaging and Cocaine Neuropharmacology in Monkeys$607,642
R37 · FY2012 · DA · contact PI
Cocaine Use and Monoamine Function$412,995
R01 · FY2012 · DA · contact PI
Neuropharmacology of Abused Stimulants in Nonhuman Primates$123,736
K05 · FY2012 · DA · contact PI
PET Imaging and Cocaine Neuropharmacology in Monkeys$563,983
R37 · FY2011 · DA · contact PI
Cocaine Use and Monoamine Function$445,701
R01 · FY2011 · DA · contact PI
IMAGING CENTER$82,318
P51 · FY2011 · RR · contact PI
PET IMAGING & COCAINE NEUROPHARMACOLOGY IN MONKEYS$41,159
P51 · FY2011 · RR · contact PI
COCAINE USE & MONOAMINE FUNCTION IN NON HUMAN PRIMATES$32,906
P51 · FY2011 · RR · contact PI
FUNCTIONAL BRAIN ACTIVITY AFTER COCAINE USE & EXTINCTION THERAPY IN NHP$32,906
P51 · FY2011 · RR · contact PI
PET Imaging and Cocaine Neuropharmacology in Monkeys$493,114
R37 · FY2010 · DA · contact PI
Cocaine Use and Monoamine Function$438,743
R01 · FY2010 · DA · contact PI
Neuropharmacology of Cocaine in Nonhuman Primates$121,208
K02 · FY2010 · DA · contact PI
IMAGING CENTER$109,655
P51 · FY2010 · RR · contact PI
PET IMAGING & COCAINE NEUROPHARMACOLOGY IN MONKEYS$54,827
P51 · FY2010 · RR · contact PI
TRANSITIONAL STATES IN DRUG ADDICTION$54,827
P51 · FY2010 · RR · contact PI
COCAINE USE & MONOAMINE FUNCTION IN NON HUMAN PRIMATES$43,862
P51 · FY2010 · RR · contact PI
PET Imaging and Cocaine Neuropharmacology in Monkeys$484,488
R37 · FY2009 · DA · contact PI
Cocaine Use and Monoamine Function$392,594
R01 · FY2009 · DA · contact PI
Neuropharmacology of Cocaine in Nonhuman Primates$121,208
K02 · FY2009 · DA · contact PI
IMAGING CENTER$109,601
P51 · FY2009 · RR · contact PI
TRANSITIONAL STATES IN DRUG ADDICTION$54,800
P51 · FY2009 · RR · contact PI
PET IMAGING & COCAINE NEUROPHARMACOLOGY IN MONKEYS$54,800
P51 · FY2009 · RR · contact PI
COCAINE USE & MONOAMINE FUNCTION IN NON HUMAN PRIMATES$43,907
P51 · FY2009 · RR · contact PI
PET Imaging and Cocaine Neuropharmacology in Monkeys$518,754
R37 · FY2008 · DA · contact PI
Cocaine Use and Monoamine Function$392,594
R01 · FY2008 · DA · contact PI
Neuropharmacology of Cocaine in Nonhuman Primates$121,208
K02 · FY2008 · DA · contact PI
PET IMAGING & COCAINE NEUROPHARMACOLOGY IN MONKEYS$35,600
P51 · FY2008 · RR · contact PI
TRANSITIONAL STATES IN DRUG ADDICTION$35,600
P51 · FY2008 · RR · contact PI
COCAINE USE & MONOAMINE FUNCTION IN NON HUMAN PRIMATES$28,536
P51 · FY2008 · RR · contact PI
PET Imaging and Cocaine Neuropharmacology in Monkeys$463,506
R37 · FY2007 · DA · contact PI
Transitional States in Drug Addiction$399,854
R01 · FY2007 · DA · contact PI
Cocaine Use and Monoamine Function$360,546
R01 · FY2007 · DA · contact PI
Neuropharmacology of Cocaine in Nonhuman Primates$121,208
K02 · FY2007 · DA · contact PI
COCAINE USE % PHARMACOTHERAPY EFFECTIVENESS IN MONKEYS$108,426
U19 · FY2007 · DA · contact PI
TRANSITIONAL STATES IN DRUG ADDICTION$39,497
P51 · FY2007 · RR · contact PI
PET IMAGING & COCAINE NEUROPHARMACOLOGY IN MONKEYS$39,497
P51 · FY2007 · RR · contact PI
COCAINE USE & MONOAMINE FUNCTION IN NON HUMAN PRIMATES$31,598
P51 · FY2007 · RR · contact PI
PET Imaging and Cocaine Neuropharmacology in Monkeys$463,753
R01 · FY2006 · DA · contact PI
Transitional States in Drug Addiction$452,181
R01 · FY2006 · DA · contact PI
Cocaine Use and Monoamine Function$371,315
R01 · FY2006 · DA · contact PI
Neuropharmacology of Cocaine in Nonhuman Primates$121,208
K02 · FY2006 · DA · contact PI
DEVELOPMENT OF FMRI FOR BEHAVIORAL STUDIES IN NONHUMAN PRIMATES$40,116
P51 · FY2006 · RR · contact PI
COCAINE USE & MONOAMINE FUNCTION IN NON HUMAN PRIMATES$40,116
P51 · FY2006 · RR · contact PI
TRANSITIONAL STATES IN DRUG ADDICTION$40,116
P51 · FY2006 · RR · contact PI
PET IMAGING & COCAINE NEUROPHARMACOLOGY IN MONKEYS$40,116
P51 · FY2006 · RR · contact PI
Transitional States in Drug Addiction$478,564
R01 · FY2005 · DA
PET Imaging and Cocaine Neuropharmacology$400,000
R01 · FY2005 · DA
Cocaine Use and Monoamine Function$338,000
R01 · FY2005 · DA
NEUROPHARMACOLOGY OF COCAINE$117,255
K02 · FY2005 · DA
DEVELOPMENT OF FMRI FOR BEHAVIORAL STUDIES IN NONHUMAN PRIMATES$32,021
P51 · FY2005 · RR
COCAINE USE AND PHARMACOTHERAPY EFFECTIVENESS IN MONKEYS$32,021
P51 · FY2005 · RR
PET IMAGING &COCAINE NEUROPHARMACOLOGY IN MONKEYS$32,021
P51 · FY2005 · RR
TRANSITIONAL STATES IN DRUG ADDICTION$30,784
P51 · FY2005 · RR
COCAINE USE &MONOAMINE FUNCTION IN NON HUMAN PRIMATES$15,428
P51 · FY2005 · RR
Transitional States in Drug Addiction$407,373
R01 · FY2004 · DA
PET Imaging and Cocaine Neuropharmacology$400,000
R01 · FY2004 · DA
COCAINE USE AND MONOAMINE FUNCTION IN NONHUMAN PRIMATES$304,197
R01 · FY2004 · DA
NEUROPHARMACOLOGY OF COCAINE$99,238
K02 · FY2004 · DA
COCAINE USE AND PHARMACOTHERAPY EFFECTIVENESS IN MONKEYS$35,765
P51 · FY2004 · RR
PET IMAGING &COCAINE NEUROPHARMACOLOGY IN MONKEYS$35,765
P51 · FY2004 · RR
DEVELOPMENT OF FMRI FOR BEHAVIORAL STUDIES IN PRIMATES$35,765
P51 · FY2004 · RR
TRANSITIONAL STATES IN DRUG ADDICTION$34,361
P51 · FY2004 · RR
COCAINE USE &MONOAMINE FUNCTION IN NON HUMAN PRIMATES$17,180
P51 · FY2004 · RR
COCAINE USE AND MONOAMINE FUNCTION IN NONHUMAN PRIMATES$17,111
R01 · FY2004 · DA
Transitional States in Drug Addiction$413,181
R01 · FY2003 · DA
PET Imaging and Cocaine Neuropharmacology$400,000
R01 · FY2003 · DA
COCAINE USE AND MONOAMINE FUNCTION IN NONHUMAN PRIMATES$295,336
R01 · FY2003 · DA
NEUROPHARMACOLOGY OF COCAINE$95,879
K02 · FY2003 · DA
COCAINE USE AND PHARMACOTHERAPY EFFECTIVENESS IN MONKEYS$31,173
P51 · FY2003 · RR
DEVELOPMENT OF FMRI FOR BEHAVIORAL STUDIES IN NONHUMAN PRIMATES$31,173
P51 · FY2003 · RR
PET IMAGING &COCAINE NEUROPHARMACOLOGY IN MONKEYS$31,173
P51 · FY2003 · RR
COCAINE USE &MONOAMINE FUNCTION IN NON HUMAN PRIMATES$14,951
P51 · FY2003 · RR
PET Imaging and Cocaine Neuropharmacology$400,000
R01 · FY2002 · DA
COCAINE USE AND MONOAMINE FUNCTION IN NONHUMAN PRIMATES$286,734
R01 · FY2002 · DA
PET IMAGING &COCAINE NEUROPHARMACOLOGY IN MONKEYS$209,143
P51 · FY2002 · RR
COCAINE USE &MONOAMINE FUNCTION IN NON HUMAN PRIMATES$209,143
P51 · FY2002 · RR
NEUROPHARMACOLOGY OF COCAINE$90,897
K02 · FY2002 · DA
PET Imaging and Cocaine Neuropharmacology$400,000
R01 · FY2001 · DA
COCAINE USE AND MONOAMINE FUNCTION IN NONHUMAN PRIMATES$278,382
R01 · FY2001 · DA
NEUROPHARMACOLOGY OF COCAINE$76,480
K02 · FY2001 · DA
COCAINE USE AND MONOAMINE FUNCTION IN NONHUMAN PRIMATES$269,532
R01 · FY2000 · DA
PET IMAGING AND COCAINE NEUROPHARMACOLOGY IN MONKEYS$250,383
R01 · FY2000 · DA
COCAINE USE &MONOAMINE FUNCTION IN NON HUMAN PRIMATES$38,495
P51 · FY2000 · RR
PET IMAGING &COCAINE NEUROPHARMACOLOGY IN MONKEYS$38,495
P51 · FY2000 · RR
CNS GRAFTING FOR PARKINSONISM$38,495
P51 · FY2000 · RR